Crosslink Therapeutics
Boston, US · Founded 2021 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
RD
Ronald D. Seidel, IIIExecutive Officer, Director
CG
Cameron GallagherDirector
LT
Lou TartagliaDirector
RC
Rodolfo ChaparroDirector
AK
Andrew KingExecutive Officer
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$4.3MraisedMay 2025 · 6 investors · PharmaceuticalsRule 506(b)
▶$4.3MraisedMay 2025 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ronald D. Seidel, IIIExecutive Officer, Director
- Cameron GallagherDirector
- Lou TartagliaDirector
- Rodolfo ChaparroDirector
- Andrew KingExecutive Officer
- Offering amount
- $8M
- Amount sold
- $4.3M
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.